EyePod

Glaucoma is a leading cause of irreversible blindness and affects approximately 80 million people globally, with projections to exceed .111 million by 2040.   We know that the elevated intraocular pressure is the key modifiable risk factor which is why reducing intraocular pressure is central to treatment strategies. In this podcast, expert faculty from the featured symposium at the 2025 EnVis...

Thyroid eye disease (TED), a rare autoimmune condition, can be sight-threatening, debilitating, and disfiguring, severely impacting patients’ quality of life and daily functioning. Traditional management approaches for TED have centered on immunomodulatory therapy and surgical interventions. In January 2020, the US Food and Drug Administration (FDA) approved teprotumumab, the first therapy spec...

Recently approved anti-VEGF agents that target additional pathways and offer innovative delivery methods with longer-lasting effects may provide advantages over older anti-VEGF agents in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). In this podcast, expert faculty discuss the roles of ophthalmologists and optometrists in managing nA...

Geographic atrophy, an advanced stage of age-related macular degeneration, is a significant cause of vision loss. Given the progressive nature of geographic atrophy and its significant impact on quality of life, educating health care professionals about the disease burden, diagnostic strategies, and evolving management strategies is essential. This PER On-Air Ophthalmology Times podcast provid...

The lacrimal functional unit, which includes the lacrimal glands and meibomian glands, can be stimulated via the trigeminal nerve to trigger production of the tear film. This approach can be used to manage dry eye disease (DED) in patients undergoing corneal refractive surgery. In this podcast, an expert explores opportunities to use this approach to treat patients with DED.

The 14th annual Glaucoma 360 conference will take place February 6 to 8, 2025, at the Westin St. Francis on Union Square in San Francisco, California. Co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, the three-day event highlights progress in glaucoma care while fostering innovation and collaboration. The conference opens on Thursday, Februa...

The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-friendly, multispecialty CME ophthalmology conference, along with a newly introduced optometry track. Henderson sits down with Ophthalmology Times' Sheryl Stevenson, group editorial director - eye care, to talk about the 2025 conference that will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto R...

Robert T. Chang, MD, from Stanford University discusses the evolving role of large language models (LLMs) in glaucoma care. He explores how these AI tools, including popular systems like ChatGPT, can enhance communication and patient education by summarizing complex information and tailoring it to different literacy levels. Chang highlights the potential of LLMs in improving efficiency in opht...

In this third of an exclusive three-part Ophthalmology Times EyePod podcast series on innovation, we continue our discussion with Jibran Sharieff, MD, and Brandon Kingrey, MD, who are residents at the Dean McGee Eye Institute (DMEI) in Oklahoma City, Oklahoma. They recently won second place at the Eyecelerator competition held before this fall’s American Academy of Ophthalmology conference in C...

In this second of an exclusive three-part Ophthalmology Times EyePod podcast series on innovation, we continue our discussion with Jibran Sharieff, MD, and Brandon Kingrey, MD, who are residents at the Dean McGee Eye Institute (DMEI) in Oklahoma City, Oklahoma. They recently won second place at the Eyecelerator competition held before this fall’s American Academy of Ophthalmology conference in ...

In this first of an exclusive three-part Ophthalmology Times EyePod podcast series on innovation, we meet Jibran Sharieff, MD, and Brandon Kingrey, MD, who are residents at the Dean McGee Eye Institute (DMEI) in Oklahoma City, Oklahoma. They recently won second place at the Eyecelerator competition held prior to this month's American Academy of Ophthalmology conference in Chicago, receiving a $...

Take a look at a review of the highlights from Ophthalmology Times during the week of September 29, 2024.

Peter J. McDonnell, MD, and Laura M. Periman, MD, discuss how artificial intelligence (AI) is transforming ophthalmology, especially in ocular surface disease. Dr. Periman highlights the potential of AI to streamline eye health screening and documentation, enabling ophthalmologists to focus on patients who require treatment. They emphasize how AI can enhance clinical efficiency, improve patient...

Take a look at a review of the highlights from Ophthalmology Times during the week of September 29, 2024.

Take a look at a review of the highlights from Ophthalmology Times during the week of September 22, 2024.

Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, Department of Ophthalmology, Faculty of Medical and Health Sciences, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias. Green outlines the status ...

Take a look at a review of the highlights from Ophthalmology Times during the week of September 15, 2024.

X-linked retinitis pigmentosa (XLRP) is a progressive disease that is more severe than other forms of RP. Affected male patients typically inherit a pathogenic variant of the RPGR gene on the X chromosome. In this podcast, an expert panel discusses diagnosing XLRP and provides an overview of clinical trials of gene therapies for XLRP.

Thyroid eye disease is a condition frequently associated with Graves disease that involves both acute and chronic inflammation of the orbit. Patients may experience ocular discomfort, appearance changes, and vision loss. In this podcast, an expert panel discusses diagnosing TED and providing appropriate pharmacologic and surgical treatments.

John Kitchens, MD, sits down with David Brown, MD, to discuss the PULSAR results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

John Kitchens, MD, sits down with Diana Do, MD, to discuss the PHOTON results and their relation to patients with diabetic macular edema in clinical practice.

John Kitchens, MD, is joined by Peter Kaiser, MD, to discuss higher molar dose and its translation into clinical practice

This PER On Air - Ophthalmology Times podcast examines the new treatment paradigm for patients with geographic atropy, following the introduction of complement-targeting therapies. In this podcast, experts, Dr Cecelia Koetting and Dr Talia Kaden review some of the key highlights from the live satellite symposium, Community Practice Connection™: Mastering the New Treatment Paradigm in Geographic...

In this PER On Air Ophthalmology Times podcast, a team of experts provides insights into the diagnosis and management of patients with NK (including assessing their underlying cause of NK), with a look at the range of treatments available for patients with advanced stages of NK.

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment. Faculty: Roger A. Goldberg, MD, MBA Vitreoretinal Specialist Bay Area Retina Associates Volunteer Faculty Cal...

In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, to learn about the progress in developing a stem cell patch for treating advanced dry age-related macular degeneration. Developed by a team of researchers at USC, the stem cell patch represents a significant advancement in treatment. Dr. Humayun talks about the inspiration behind the p...

This podcast features engaging commentary from experts in the clinical management of glaucoma. These experts share information about traditional and newer therapies for glaucoma, including topical drops, sustained drug delivery options, and minimally invasive glaucoma surgery. They discuss safety and efficacy data with an emphasis on appropriate patient selection, as well as key take-home point...

The role of calendars may be growing more important when managing patients with nAMD and DME. How many weeks can patients go between injections with newer anti-VEGF agents versus older options? How short of an injection interval can patients tolerate before it becomes too much of a burden? In this podcast, Murtaza Adam, MD; Laxmi Devisetty, MD, Hong-Uyen Hua, MD; and Sherrol Reynolds, OD; shar...

Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis

Tune in to the first of a new series of Ophthalmology Times EyePod podcasts focusing on innovation in ophthalmology. Throughout this series, we'll be hearing insights from various stakeholders including those in clinical practice, academia, and industry. The overarching message in this podcast is intended to be informational and not promotional. Today, our host Ehsan Sadri, MD, will be in conve...

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023.

In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.

Take a look at a review of the highlights from Ophthalmology Times during the week of January 21, 2024.

Take a look at a review of the highlights from Ophthalmology Times during the week of January 7, 2024.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023.

Explore the practical side of femtosecond laser-assisted cataract surgery (FLACS) with Neda Shamie, MD, and Peter J. McDonnell, MD. In this podcast, they discuss real-world experiences, patient choices, and the nuances of integrating FLACS into practice, offering insights into the latest developments in ophthalmology.

In this episode, Neda Shamie, MD, and Peter J. McDonnell, MD, discuss the benefits and challenges of implementing the many options from the premium lens pipeline into practice, emphasizing the importance of customization based on patients' lifestyles and expectations, while also addressing concerns and sharing their positive experiences with the evolving technology in the field.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of December 2, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023.

Peter J. McDonnell, MD, and Neda Shamie, MD, consider the transformative landscape of cataract surgery, highlighting the impact of small-aperture IOL technology. The conversation delves into its potential benefits, influence on the market, and the evolving role of cataract surgeons in guiding patients through advanced options.

Welcome to this special edition of the Ophthalmology Times® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast features an international panel of ophthalmologists, including Arshad M. Khanani, MD, MA, FASRS; Carl J. Danzig, MD, FASRS; and Anat Loewenstein, MD, MHA, who will discuss unmet needs in the treatment of neovascular age-related macular degeneration (nAMD) ...

Welcome to this special edition of the Ophthalmology Times® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast examines how key therapies for treating diabetic macular edema—anti-VEGF agents and corticosteroids—address the underlying pathophysiology of the condition to effectively and safely treat it. In this podcast, 3 ophthalmologists—Fernando Arevalo, MD; Peter ...

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of October 1, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of September 24,  2023.

In this EyePod® episode, David Hutton sits down with Shankar Musunuru, CEO of Ocugen to discuss updated data for OCU400.

Peter J. McDonnell, MD, and Neda Shamie, MD, discuss the transformative impact of minimally invasive glaucoma surgery (MIGS) on glaucoma care and its integration with cataract surgery, sharing insights and practical tips for ophthalmologists.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of September 17, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of September 10, 2023.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 4 of the Viewpoints Podcast.